Current Trials
Don't wait, Participate! View our current trials open for enrollment. Fill out a confidential questionnaire or call us to see if you qualify.
read more
Patients
CIS is currently conducting a variety of FDA approved clinical trials which may be of benefit to you. Click below to see how participating in a clinical trial may benefit you, or click on current trials to view our current trials.
Physicians
Join out team. We are committed to providing our physicians network with the best of tools to perform quality clinical research.
Sponsors
With multi-site capability, CIS has a wealth of experience conducting pivotal clinical trials in all the major therapeutic areas. Our goal is to provide high quality data in a timely and efficient manner while providing patient care in a personalized environment.
Read More
Navigation
Home
Clinical Investigation Specialists, Inc. (CIS), is an independent, premier Clinical Research Management Organization. CIS has conducted Phases I-IV clinical trials for pharmaceutical and biotechnology companies.
CIS is committed to providing personalized attention and services by utilizing resources other companies cannot provide. We maintain a proactive pursuit of value added services to meet our clients' changing needs.
Our extensive CIS/MD Network consists of the most qualified Board Certified physicians covering all major therapeutic areas. We are proud to break the mold by distinguishing ourselves as a clinical research management organization that is on the cutting edge of medicine.
CIS offers not only services you may receive from a CRO & SMO, but also services encompassed by a hands on Research Management Organization. Sounds like a smart choice for companies looking for an efficient means to move their products through the pipeline with more personalized attention.
There are many advantages when you choose CIS for your upcoming trials. Our experienced Investigators and Research Coordinators offer innovative ideas every step of the way to help you achieve your desired results.
